Dr Steven Yeh Explains Xipere Follow-up Findings, Learning Curves for Clinicians
May 2nd 2022Steven Yeh, MD, professor of ophthalmology at the Truhlsen Eye Institute at the University of Nebraska Medical Center, discusses the length of Xipere's treatment benefits and potential learning curves regarding its suprachoroidal delivery mechanism.
Watch
The FDA sets a tentative date for a decision on authorizing a COVID-19 vaccine in children under 5 years of age; the American Academy of Pediatrics will review all of its guidance for unproven race-based recommendations contributing to health disparities; the FDA rejects 2 China-tested cancer treatments.
Read More
Poorer Outcomes Associated With Recurrent aGVHD Warrant Independent Recognition, Says Study
May 2nd 2022After a median follow-up of 535 days, analysis showed that recurrent acute graft-versus-host disease (RaGVHD) carried several implications for survival, leading the researchers to call for further risk stratification of aGVHD.
Read More
Study Gives Insight Into Fidaxomicin’s Gut-Sparing Activity in Clostridioides difficile
May 2nd 2022Fidaxomicin, now commonly used to treat Clostridioides difficile infection, selectively targets the bacterium while sparing crucial gut commensals that protect against colonization. However, knowledge gaps in the molecular basis of its narrow-spectrum activity remain.
Read More
RNA Sequencing Identifies Novel, Specific Biomarkers in Pterygia
May 1st 2022While risk factors for pterygia are well-known, the underlying disease mechanisms have not been fully clarified in past studies. A new analysis using RNA sequencing pinpointed ptergyia-specific biomarkers and potential therapeutic targets.
Read More
Hypomethylating Agents With Venetoclax Can Be Effective Bridge to Transplant in AML
May 1st 2022Among a cohort of 88 patients with acute myeloid leukemia who received hypomethylating agents with venetoclax prior to allogeneic hematopoietic cell transplant, 85% had achieved morphologic complete response at 100 days.
Read More
Contributor: Exploring the Patient Experience as a Driver for Loyalty in the Digital Age
May 1st 2022In this contributor piece, Gary Hamilton, CEO of InteliChart, the online patient engagement platform, explores how the digital evolution in health care can lead to quality care, convenience, and ongoing patient loyalty.
Read More
Study Finds Risk of Overinvestigation in Patients With Lung Cancer Not Fit for Anticancer Treatment
April 30th 2022Among a group of patients with lung cancer who were not suitable for anticancer treatment, the researchers found that 40% underwent additional investigations after their initial CT scan before eventually receiving best supportive care.
Read More
Real-Time CGM Can Help Shape Patient Education, Glycemic Index Measures in T2D
April 30th 2022Investigators from Malaysia utilized data from real-time continuous glucose monitoring (CGM) among study participants who were considered overweight or obese to evaluate their risk of type 2 diabetes (T2D) associated with a rice-based meal and its impact on postprandial hyperglycemia.
Read More
HPV Infection May Increase Risk of Developing CRS With Nasal Polyps
April 30th 2022Presence of human papillomavirus (HPV) was significantly associated with incidence of chronic rhinosinusitis with nasal polyps (CRSwNP), although no differences in disease severity were observed among HPV-positive and HPV-negative patients with CRSwNP.
Read More
Study: Effective Treatment Significantly Improves HRQoL in Recurrent Clostridioides difficile
April 30th 2022The researchers wrote that their findings showcase the need for close monitoring of patients and for effective treatments for those with recurrent infection, which occurs in 15%-30% of all patients with Clostridioides difficile.
Read More
Dr Patricia Deverka Discusses Access, Research for Multicancer Early Detection Tests
April 29th 2022Patricia Deverka, MD, MS, senior researcher, deputy director at the Center for Translational and Policy Research and Precision Medicine, University of California San Francisco, explains what multicancer early detection tests currently exist and the research needed to understand their clinical utility.
Watch
Dr Gillian Woollett Highlights International Markets With Successful Biosimilar Adoption
April 29th 2022Gillian Woollett, MA, Dphil, vice president and head of regulatory strategy and policy at Samsung Bioepis, gives insight into what international markets the United States could look to as examples of good biosimilar adoption.
Watch
Dr Jason Myers Discusses How New Zealand Pivoted to Continue HIV Care During the Pandemic
April 29th 2022Jason Myers, PhD, CEO of the New Zealand AIDS Foundation, addresses how New Zealand promptly adjusted its delivery of services for people living with HIV and AIDS in New Zealand, with examples including HIV self-test kits, online counseling, and provision of mental health care assistance.
Watch
What We’re Reading: Mavacamten Approved for HCM; Oklahoma Abortion Bans; Baby Formula Whistleblower
April 29th 2022A new drug has been approved for obstructive hypertrophic cardiomyopathy (HCM); Oklahoma enacts a strict abortion ban; whistleblower claims alarms had been raised about Abbott baby formula contamination.
Read More